Technavio has announced the release of their research report on the global aneurysm coiling and embolization devices market for the forecast period 2019-2023. This global aneurysm coiling and embolization devices market analysis report segments the market by product (embolization coils, balloon, and stent-assisted coils, access and delivery devices, aneurysm clips, and flow diversion devices) and geography (Asia, Europe, North America, and ROW).
Global aneurysm coiling and embolization devices market will grow by almost USD 1.61 billion during 2019-2023, at a CAGR of more than 10%. Many vendors are increasing their R&D efforts to launch new products to stay ahead of the competition. For example, InspireMD is developing NGuard, a neurovascular flow diverter with lower metal content scaffold than existing commercial flow diverters. The low metal content is expected to reduce the need for long term-anticoagulation. In January 2018, CERENOVUS announced the launch of its smallest and softest embolic finishing coil, GALAXY G3 MINI. It has a random complex shape that can make the coil comfortable and enables it to fill open spaces in IAs. This helps in achieving high packing densities and lowers patient retreatment rates. The development of new products and the increasing R&D capabilities are expected to fuel the growth of global aneurysm coiling and embolization devices market during the forecast period.
Request for a free sample and get illustrations, table of contents, list of exhibits, and example pages from this report
Increasing frequency of UIAs detection
Technological advances such as CTA, MRA, and digital subtraction angiography have increased the detection rates of UIAs. Advanced MRI scanners like the highfield-strength 7 T MRI can detect changes in aneurysm wall thickness. Other advanced techniques such as the Time-resolved MRA or 4D MRA can measure flow velocities and shear stresses within an aneurysm. These techniques can identify the rupture site in patients with multiple IAs and allow for more accurate and timely treatment. The improving detection of UIAs is increasing the demand for neuroendovascular coiling and stenting procedures, which is expected to drive the growth of the global aneurysm coiling and embolization devices market over the forecast period.
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
The geriatric population in the North American region is at a high risk of developing IAs, which increases the demand for aneurysm coiling and embolization devices in the region. Furthermore, the strong presence of established vendors, increased healthcare expenditure, and the increasing presence of IAs and related risk factors in the region will also drive market growth in North America. The APAC region will witness faster growth during the forecast period. The high unmet demand for quality healthcare and increasing government initiatives to improve the healthcare infrastructure in the region will drive market growth during the forecast period, says an analyst at Technavio.
MicroPort Scientific Corporation recently gained CFDA approval for its in-house developed Tubridge Vascular Reconstruction Device. The device can successfully reconstruct cerebrovascular and has high durability. It is also expected to lower the recurrence rates to less than 5%. Cerus Endovascular received the CE mark for the sale of its Contour Neurovascular System for the treatment of IAs. It can be used for the treatment of both ruptured and unruptured IAs. Many such advancements among vendors are expected to drive the market growth during the forecast period.
View snapshot of the report for a more detailed overview of the market and the segmentation covered in this report
This global aneurysm coiling and embolization devices industry research report provides an in-depth analysis of the major drivers, upcoming trends, and challenges that will impact market growth over the forecast period. The report analyzes the competitive landscape and offers details on several aneurysm coiling and embolization device manufacturers including –
- Acandis GmbH
- Johnson & Johnson Services, Inc.
- Penumbra, Inc.
- TERUMO CORPORATION
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market size and forecast
Five Forces Analysis
- Regional comparison
- Key leading countries
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. Technavios report library consists of more than 10,000 reports covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies.
Please contact our media team at [email protected] for more information.
Media & Marketing Executive
+1 844 364 1100
UK: +44 203 893 3200